|
EIF1AX expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.55850000074886E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.57019999622332E-08 |
| Normal-vs-Stage2 |
2.553900E-04 |
| Normal-vs-Stage3 |
1.547920E-02 |
| Normal-vs-Stage4 |
5.510000E-02 |
| Stage1-vs-Stage2 |
5.506800E-01 |
| Stage1-vs-Stage3 |
5.973600E-02 |
| Stage1-vs-Stage4 |
1.434030E-01 |
| Stage2-vs-Stage3 |
4.144400E-01 |
| Stage2-vs-Stage4 |
3.979600E-01 |
| Stage3-vs-Stage4 |
8.824400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.32929999732789E-08 |
| Normal-vs-AfricanAmerican |
7.45399999946272E-07 |
| Normal-vs-Asian |
9.990100E-02 |
| Caucasian-vs-AfricanAmerican |
9.424000E-01 |
| Caucasian-vs-Asian |
4.013600E-01 |
| AfricanAmerican-vs-Asian |
4.106200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
7.372200E-01 |
| Male-vs-Female |
4.62070381956892E-11 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.164480E-03 |
| Normal-vs-Extreme_Weight |
5.00929997482302E-09 |
| Normal-vs-Obese |
3.66740000001808E-06 |
| Normal-vs-Extreme_Obese |
2.01129999999328E-05 |
| Normal_Weight-vs-Extreme_Weight |
5.264000E-02 |
| Normal_Weight-vs-Obese |
3.761800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.600100E-02 |
| Extreme_Weight-vs-Obese |
1.618980E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.850800E-01 |
| Obese-vs-Extreme_Obese |
2.517400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.287170E-01 |
| Normal-vs-Age(41-60Yrs) |
3.86850000000383E-06 |
| Normal-vs-Age(61-80Yrs) |
7.17730319621523E-11 |
| Normal-vs-Age(81-100Yrs) |
6.563000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.843360E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.817060E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.496960E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.263900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.953000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.522800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.06059613816478E-11 |
| Normal-VS-Type2 PRCC |
6.07449999967535E-07 |
| Normal-VS-KIRP CIMP |
5.636200E-01 |
| Normal-VS-Unclassified PRCC |
2.797800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.964600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.281700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.316200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.193000E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
7.047400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.578800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.31770047598445E-10 |
| Normal-vs-N1 |
2.431400E-01 |
| Normal-vs-N2 |
6.268400E-01 |
| N0-vs-N1 |
1.246160E-02 |
| N0-vs-N2 |
4.308800E-01 |
| N1-vs-N2 |
9.299800E-01 |
|
|
